RxDoctor Payments Data

Piyush Buch, MD

Psychiatry · Palos Heights, ILNPI 1841225349

Payments from drug & device makers

$697in general payments, 2019–2025

Across 53 payments — averaging $13.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$197
  • AbbVie$194
  • Sunovion Pharmaceuticals Inc.$117
  • Teva Pharmaceuticals USA, Inc.$57
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$47
  • Alkermes, Inc.$34
  • plus $51 from 3 others

What the payments were for

  • Food & beverage$65093%
  • Education$477%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$697 in reported general payments places this provider in the 70th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$53,704
Medicare patients
98
Services billed
743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole11$36,435
Aripiprazole155$12,120
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl172$10,853
TrintellixVortioxetine Hydrobromide19$8,922
Quetiapine Fumarate278$5,292
Alprazolam583$4,172
Lurasidone Hcl25$3,904
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine118$3,293
Ziprasidone Hcl74$3,158
Divalproex Sodium ErDivalproex Sodium56$2,938
Buprenorphine Hcl58$2,716
Olanzapine135$1,907
Venlafaxine Hcl ErVenlafaxine Hcl160$1,741
Duloxetine Hcl176$1,500
Risperidone275$1,497

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$197$36,43511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Palos Heights

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →